Therapeutic Approach

Archive: December, 2011

Ritter Pharmaceuticals Appoints Robert H. Tidwell to Chief Business Officer

LOS ANGELES – December 8, 2011 – Ritter Pharmaceuticals, Inc. (Ritter Pharma) has appointed Robert H. Tidwell as chief business officer. Mr. Tidwell brings over 30 years of biotechnology and pharmaceutical industry experience to Ritter Pharma as the Company prepares to partner its proprietary Phase 2 compound, RP-G28, for the treatment of lactose intolerance. Mr. […]

Leave Your Comments »

Featuring Recent Posts WordPress Widget development by YD